Advertisement Pharmaceutical Business review - Page 469 of 5285 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 7, 2026

Evotec and Odyssey collaborate on AI-enabled R&D

Evotec and Odyssey Therapeutics have announced a strategic AI-enabled research and development (R&D) partnership to explore new treatments for autoimmune and inflammatory diseases.

Continue
The companies seek to identify validated hit series and advance encouraging therapeutic programmes. Credit: Zolnierek_photography / Shutterstock.com.
August 6, 2026

Alteogen signs $365m Hybrozyme licensing deal with pharma company

Alteogen operates in the development and commercialisation of biologics such as antibody-drug conjugates, biobetters, and biosimilars. Credit: Quality Stock Arts / Shutterstock.com.
August 5, 2026

Phylo and Chugai collaborate to deploy AI platform in drug discovery

The platform will be used across Chugai’s research, including human genetics, disease biology, and target evaluation. Credit: Gorodenkoff / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Mediar and Ono Pharmaceutical to develop fibro-inflammatory treatments
  2. Schrödinger and BMS expand partnership to deploy AI for drug discovery
  3. AsymBio to secure $184m to support growth in biologics manufacturing
  4. FDA grants breakthrough therapy designation to Lilly’s olomorasib
  5. Curium to acquire Lantheus in all-cash deal worth up to $8bn

PRESS RELEASES

SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography